The farming industry has no shortage of innovation, but the challenge is turning promising technology into practical ...

What does it take to turn world-class science into a commercial success story? For KluraLabs, the journey has taken the ...

Cambridge biotech Epitopea doses first patient in its UK Phase 1 clinical trial of CryptiVax-1001, a novel mRNA cancer ...

Cambridge biotech T-Therapeutics secures $133M in Series B funding co-led by Advent Life Sciences and British Business Bank ...

AbbVie has expanded its Oxford R&D facility with a new 12,000 sq ft site, scaling UK research in immunology, neuroscience, ...

The PEM Corporate Finance team demonstrated its reach way beyond Cambridge as it acted as lead adviser to shareholders of ...

Arm reports record Q2 revenue of $1.44B, up 27% on surging AI compute demand, cloud chip market share crossing 50%, and early ...

Kate Wood, Planning Director, Property Agency, BTG Eddisons unpicks some salient points of the NPPF when it comes to ...

PwC’s latest UK M & A research shows that deal value more than doubled in the first half of 2026, reaching £134.7 billion, while the number of announced transactions fell by almost 13 per cent to ...

The Oxbridge Arc dividend and a presence in Japan and the US for the respective participants could trigger a massive ...

ScottishPower Renewables has awarded the design and build contract for its new East Anglia offshore windfarm base to local ...

Wellcome Genome Campus has appointed Winvic Construction Ltd to deliver two landmark pedestrian bridges across the A1301, ...